Investing.com - Financial Markets Worldwide
Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Japan stocks rise as COVID-19 vaccine trials support growth outlook

Published 07/21/2020, 10:36 AM
Updated 07/21/2020, 10:40 AM
TOPX
-
7202
-
4568
-
4689
-
5233
-
8253
-
9433
-
9437
-
3436
-

By Stanley White
TOKYO, July 21 (Reuters) - Japanese stocks rose on Tuesday
as signs of progress in developing a COVID-19 vaccine boosted
investor confidence in the outlook for future economic growth.
The Nikkei index was up 0.60% to 22,854.74 by 0203 GMT, with
the healthcare and technology sectors leading the advance.
Initial findings from trials of three potential COVID-19
vaccines have shown encouraging results, raising hopes for a
medical solution to a global pandemic that has triggered a sharp
recession and caused more than half a million deaths.
There were 63 advancers in the Nikkei index against 157
decliners on Tuesday.
The largest percentage gainers in the index were
pharmaceutical firm Daiichi Sankyo Co Ltd 4568.T up 5.09%,
followed by silicon wafer maker Sumco Corp 3436.T gaining
4.61%, and Internet services firm Z Holdings Corp 4689.T up by
4.59%.
The largest percentage losses in the index were auto maker
Isuzu Motors Ltd 7202.T down 3.83%, followed by Taiheiyo
Cement Corp 5233.T losing 3.66%, and credit card firm Credit
Saison Co Ltd 8253.T down by 3.6%.
Shares of mobile phone network operators NTT Docomo Inc
9437.T , KDDI Corp 9433.T , and Softbank Corp 0434.T dropped
following a report that Japan's government is considering
preventing wireless carriers from charging customers fees when
they switch providers.
The broader Topix .TOPX rose 0.06% to 1,577.97.
The volume of shares traded on the Tokyo Stock Exchange's
main board .TOPX was 0.53 billion, compared with the average
of 1.25 billion in the past 30 days.

(Editing by Sherry Jacob-Phillips)

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.